Clinical Trials Sponsored by SEREFO
Total 493 results
-
EMD Serono Research & Development Institute, Inc.CompletedMultiple SclerosisUnited States, Italy, Russian Federation, Spain
-
Cereno Scientific ABCompleted
-
EMD SeronoSanofiCompletedMelanoma | Breast Cancer | Colorectal Cancer | Non Small Cell Lung Cancer | Metastatic Solid Tumor | Locally Advanced Solid TumorUnited States, Italy, Spain
-
EMD SeronoPfizerCompletedMultiple SclerosisUnited States
-
EMD SeronoPfizerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)United States
-
Cirujanos la SerenaWithdrawnGastroenteritis | AppendicitisChile
-
Cirujanos la SerenaCompleted
-
Hospital Severo OchoaTerminatedPostpolypectomy BleedingSpain
-
Cirujanos la SerenaCompletedGastrointestinal Stromal TumorsChile
-
Cirujanos la SerenaCompletedGallstones | Gallbladder CholesterolosisChile
-
Mereo BioPharmaCompleted
-
Mereo BioPharmaCompletedPulmonary Disease, Chronic ObstructiveUnited States, Bulgaria, Czechia, Germany, Hungary, Italy, Latvia, Poland, Romania, Russian Federation
-
Mereo BioPharmaCompleted
-
Gazi UniversitySeroxo LtdCompletedInfections | Sepsis | Septic ShockTurkey
-
Hospital de La SerenaCompleted
-
Seres Therapeutics, Inc.CompletedClostridioides Difficile InfectionUnited States, Canada
-
Mereo BioPharmaNovartisCompletedChronic Obstructive Pulmonary DiseaseRussian Federation, Bulgaria, Romania
-
Mereo BioPharmaNovartisTerminatedPelvic Pain Associated With Refractory EndometriosisUnited States, Puerto Rico
-
Mereo BioPharmaNovartisTerminatedAcute Kidney InjuryTaiwan, United States, Israel
-
Clinique OvoEMD SeronoCompleted
-
Heidelberg UniversitySerono GmbHCompletedMultiple Sclerosis | Macular Edema | Uveitis, IntermediateGermany
-
Northwell HealthEMD SeronoCompleted
-
UConn HealthEMD SeronoCompletedInfertilityUnited States
-
Threshold PharmaceuticalsEMD SeronoTerminatedNon-small Cell Lung CancerUnited States, Germany, Spain, Poland, Greece, Czechia, Hungary, Italy, Romania, Russian Federation
-
UConn HealthEMD SeronoCompleted
-
ANRS, Emerging Infectious DiseasesUMR 1252 SESSTIM; ARCAD Santé PLUS; SEREFOUnknown
-
Seres Therapeutics, Inc.Approved for marketingClostridioides Difficile Infection
-
Seres Therapeutics, Inc.CompletedClostridium Difficile InfectionUnited States, Canada
-
Mereo BioPharmaNovartisTerminatedObese Hypogonadotropic HypogonadismUnited States, Canada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyNot yet recruitingAdvanced Solid TumorUnited States, Germany
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingNon-Small Cell Lung CancerKorea, Republic of, United States, Japan, Spain, Italy, Belgium, France, Germany
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingColorectal CancerUnited States, Japan, Spain
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada, Spain
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingCancerUnited States, Israel, Spain, Finland, France, Belgium, Netherlands, United Kingdom, Canada, Italy, Germany, Sweden, Austria, Czechia, Portugal
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingMultiple SclerosisUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedCholangiocarcinoma | Biliary Tract Cancer | Gallbladder CancerKorea, Republic of, United States, Taiwan, Italy, France, China, Japan, Spain, United Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsCanada, United States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMultiple MyelomaUnited States, France
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid Tumor | Advanced Solid TumorSpain, United States, Netherlands, United Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionUnited States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedCoronavirus Disease 2019United States, Brazil, Philippines
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Gastric Cancer Third LineSpain, Italy, Australia, Korea, Republic of, Belgium, France, Poland, United States, Czechia, Germany
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States
-
Seres Therapeutics, Inc.TerminatedUlcerative ColitisUnited States, Canada
-
Mereo BioPharmaNovartisCompleted
-
Seres Therapeutics, Inc.CompletedUlcerative ColitisUnited States
-
University of WashingtonEMD SeronoActive, not recruitingStage III Merkel Cell Carcinoma AJCC v8 | Stage IIIB Merkel Cell Carcinoma AJCC v8 | Stage IIIA Merkel Cell Carcinoma AJCC v8United States